Marshall Wace’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Marshall Wace’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,315	Closed	-$392K	–	3077
2020 Q4	$392K	Sell	21,315 -47,057	-69%	-$858K	﹤0.01%	1581
2020 Q3	$1.25M	Buy	+68,372	New	+$1.15M	0.01%	941

Marshall Wace's CBMG Position: Q1 2021 in Review

Marshall Wace sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 21,315 shares — an estimated $392K sold.

Marshall Wace first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $1.25M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Marshall Wace reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Marshall Wace sold 21,315 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $392K.
Marshall Wace first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Marshall Wace's Cellular Biomedicine Group, Inc. position peaked at $1.25M in Q3 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.